306-N16B |
| カタログ番号GC91616 |
306-N16B is an ionizable cationic lipid.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2803699-70-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
306-N16B is an ionizable cationic lipid.[1] It has been used in the generation of lipid nanoparticles (LNPs). Intravenous administration of LNPs containing 306-N16B and encapsulating an mRNA reporter accumulate specifically in the mouse lung primarily in lung endothelial cells. LNPs containing both 306-N16B and 306-O12B and encapsulating mRNA encoding tuberous sclerosis complex 2 (Tsc2), a tumor suppressor, reduce tumor growth in a mouse model of pulmonary lymphangioleiomyomatosis (LAM) induced by intravenous injection of Tsc2-null kidney-derived epithelial tumor cells (TTJ cells).
References:
[1].Qiu, M., Tang, Y., Chen, J., et al.Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosisProc. Natl. Acad. Sci. USA119(8)e2116271119(2022).
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *